![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, June 10, 2013 12:41:41 PM
We always knew Whelan was playing with fire by alienating the folks at the FDA by challenging their decisions with the office of the Integrity Commissioner. That's like asking someone to do a report card on his boss, suicidal.
So the Commish says "nope, not gonna interfere, if you want approval, go through normal channels". And that's where we are, including being part of the FDA look at the whole PMF device review. I'm not saying this stock is going to be 10 cents soon, or anytime. But it seems to me there are shares being sold and bought and probably the MM's are making out like bandits. Whelan's PR says they are in business in many countries, I expect the management of the company to work at advancing the company.
I know the product ActiPatch works, the company's job is to prove to the FDA efficacy and safety - so do it. This is not snake oil as one person has said, it is a series of devices following RecoveryRx which was approved as an Rx product by the FDA. Good luck fuente
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM